News
Enter your email address to get Core One Labs News Alerts.
News
Enter your email address to get Core One Labs News Alerts.
Company News
Core One Labs’ Akome Achieves Significant Research Milestone with Positive Neurogenesis Stimulation Studies Results
August 18, 2022
Core One Labs’ Akome Achieves Significant Research Milestone with Positive Neurogenesis Stimulation Studies Results
Opening the Door to Expanded Patent Coverage
Vancouver,...
Read more
Company News
Core One Labs’ Vocan Successfully Converts Psilocin Precursor into Psilocybin
August 15, 2022
Vancouver, British Columbia, Canada – August 15, 2022 – Further to its press release dated August 12, 2022, Core One Labs Inc. (CSE: COOL), (OTC:
Read more
Company News
Core One Labs’ Subsidiaries Successfully Produce Psilocin Precursor for Production to Psilocybin
August 12, 2022
Vancouver, British Columbia, Canada – August 12, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Announces Warrant Repricing
August 11, 2022
Vancouver, British Columbia, Canada – August 11, 2022 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs’ Upgrades to OTCQB Venture Market
April 06, 2022
Vancouver, British Columbia, Canada – April 6, 2022 – Core One Labs Inc. (CSE: “COOL”), (OTCQB: “CLABF”), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”...
Read more
Company News
Core One Labs’ Akome Receives Positive Results from Bioassay Studies Will Look to Advance its Psychedelic Based Formulations
April 02, 2022
Vancouver, British Columbia, Canada – April 2, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”)...
Read more